Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1Neoplasm Metastasis 1

Interventions

pembrolizumab 1266Specimen Handling 927Magnetic Resonance Spectroscopy 835Carboplatin 825Cyclophosphamide 804Cisplatin 726Nivolumab 666Paclitaxel 630Radiotherapy 609Gemcitabine 571Biopsy 561Bevacizumab 481Dexamethasone 439fludarabine 409Docetaxel 377venetoclax 368Oxaliplatin 364Fluorouracil 356Capecitabine 355atezolizumab 351durvalumab 334Rituximab 332Drug Therapy 325Doxorubicin 317Radiosurgery 315Blood Specimen Collection 310Standard of Care 310Pemetrexed 305Ipilimumab 297Radiation 287

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
ferumoxtran-10 × 1 year × Clear all
NCT04261777 2026-04-28

Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients

Saving Patients' Lives Medical B.V.

Phase 3 Terminated
172 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡